Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4136859 | Pathologie Biologie | 2006 | 9 Pages |
Abstract
Use of this new assay as a first line screening would significantly reduce the long seronegative window period seen in HCV infection allowing earlier HCV diagnosis and rapid clinical management. However, in case of clinical acute hepatitis C, sensitive HCV-RNA detection should remain the gold standard.
Related Topics
Health Sciences
Medicine and Dentistry
Pathology and Medical Technology
Authors
A. Schnuriger, S. Dominguez, M.-A. Valantin, R. Tubiana, C. Duvivier, J. Ghosn, A. Simon, C. Katlama, V. Thibault,